Biochemistry of Cancer & Apoptosis: Basics Made Simple

Cancer is uncontrolled cell division driven by accumulated DNA mutations, and apoptosis is programmed cell death — the orderly self-dismantling a cell performs when it is damaged, infected, or no longer needed. The two are mirror images: cancer is largely a failure of apoptosis, the refusal of damaged cells to die on schedule.

This matters because cancer is among the leading causes of death worldwide, and nearly every cancer therapy — surgery aside — tries to force cancer cells back into apoptosis.

Key Concepts

• Proto-oncogene → oncogene: normal growth genes (like RAS) that, when mutated or overactive, drive relentless division — the accelerator stuck down.
• Tumour suppressors: the brakes — p53 (the guardian of the genome, mutated in over half of human cancers) and RB. Lose them and damaged cells keep dividing.
• Cancer hallmarks: sustained proliferation, evading apoptosis, limitless replication, angiogenesis, invasion, and metastasis.
• Warburg effect: cancer cells prefer glycolysis even with oxygen available — wasteful for energy but fast, and it supplies building blocks for new cells.
• Intrinsic apoptosis: DNA damage activates p53; mitochondria release cytochrome c; the apoptosome assembles. Extrinsic: death receptors like Fas receive a kill signal from immune cells.
• Caspases: executioner enzymes that chop proteins and DNA into neat fragments; the cell breaks into membrane-wrapped apoptotic bodies that neighbours digest — with no inflammation.

How It Works

Follow a cell with damaged DNA. Sensors activate p53, which first pauses the cell cycle for repair. If repair succeeds, the cell resumes; if the damage is beyond repair, p53 activates pro-death proteins (BAX, PUMA) that punch holes in the mitochondrial membrane. Cytochrome c spills out, the apoptosome assembles, and caspases switch on — cutting the cytoskeleton (the cell blebs), chopping DNA between nucleosomes, and flipping phosphatidylserine to the surface as an eat-me signal. Neighbours engulf the fragments within hours. In cancer, mutated p53 or overactive BCL-2 blocks this sequence, so the damaged cell survives, divides, and collects the next mutation.

Worked Example

How long does a tumour hide before detection? A 1 cm³ tumour holds roughly 10⁹ cells, grown from one cell by doubling. Step 1: 2³⁰ = 1,073,741,824, so about 30 doublings. Step 2: at 100 days per doubling — 30 × 100 = 3000 days. Step 3: 3000 ÷ 365 ≈ 8.2 years. So a tumour can grow silently for around 8 years before reaching 1 cm — which is why screening hunts for cancers years before symptoms.

Common Misconceptions

• All lumps are cancer. Most lumps are benign — lipomas, cysts, fibroadenomas. Cancer is defined by invasion and metastasis, not by being a lump.
• Apoptosis and necrosis are the same. Apoptosis is tidy, energy-dependent, and inflammation-free; necrosis is messy rupture that triggers inflammation.
• Cutting out sugar starves cancer. All cells need glucose and the body maintains blood sugar regardless of diet; the Warburg effect does not mean sugar avoidance treats cancer.

Real-World Applications

• Tumour markers (PSA, CA-125) and p53 testing guide diagnosis and prognosis.
• Chemotherapy and radiation work mainly by damaging cancer cells enough to trigger apoptosis — which is why p53-mutant tumours resist them.
• Targeted drugs like BCL-2 inhibitors (venetoclax) directly unblock the apoptosis machinery in leukaemia.
• Screening programmes are timed to the years-long silent growth window calculated above.

Cancer arises when oncogenes accelerate and tumour suppressors like p53 fail, letting damaged cells evade apoptosis and collect hallmarks from angiogenesis to metastasis. A tumour needs about 30 doublings — roughly 8 silent years — to reach 1 cm, and modern therapy increasingly means switching the death programme back on.